Breast Cancer Clinical Trials
414 studies are recruiting for breast cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 16
-
WashU DIEP Flap Video and Patient Understanding Improvement
Patients will complete a survey before and after watching the WashU DIEP Flap Video at their pre-operative standard of care visit, and a third survey at their post-operative standard of care visit. These surveys will use questions from SILS, APAIS, PEMAT, and AIM/IAM to assess the patient's health …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Washington University School of Medicine, St Louis, Missouri
- Run by
- Washington University School of Medicine
-
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.
- Stage
- Phase 2
- Ages
- 45 to 79
- Site
- Virginia Commonwealth University, Richmond, Virginia
- Run by
- Virginia Commonwealth University
-
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography resu…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Huntsman Cancer Institute/ University of Utah, Salt Lake City, Utah
- Run by
- University of Utah
-
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Adventhealth, Orlando, Florida
- Run by
- AdventHealth
-
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
This phase 1b study investigates the safety and feasibility of combining pre-operative radiation therapy with Cyclin-Dependent Kinase 4 (CDK4/6) inhibitors in participants with hormone receptor positive/HER2 negative (HR+/HER2-) breast cancer. The study aims to assess the benefits of concurrent use…
- Stage
- Phase 1
- Ages
- 60 and older
- Site
- RWJBarnabas Health Clara Maas Medical Center, Belleville, New Jersey
- Locations
- 4 in total
- Run by
- Mridula George, MD
-
Breast Re-irradiation After Second Ipsilateral Lumpectomy
The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.
- Stage
- Not phased
- Ages
- 40 and older
- Site
- Lynn Cancer Institute at Baptist Health, Inc., Boca Raton, Florida
- Locations
- 2 in total
- Run by
- Youssef Zeidan
-
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
The aim of this study is to assess feasibility of a new imaging technology in the management of breast cancer - Tumor Microenvironment of Metastasis - Magnetic Resonance imaging (TMEM-MRI).
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Montefiore Medical Center, The Bronx, New York
- Run by
- Montefiore Medical Center
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.
- Stage
- Phase 3
- Ages
- 18 to 75
- Site
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
- Locations
- 7 in total
- Run by
- Memorial Sloan Kettering Cancer Center
-
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy.
- Stage
- Phase 4
- Ages
- 18 and older
- Site
- University of Cincinnati Medical Center, Cincinnati, Ohio
- Run by
- University of Cincinnati
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
The long-term goal of this project is to improve the implementation of tailored resistance exercise interventions for Appalachian breast cancer survivors. To achieve this goal, the primary objective is to enhance the understanding of how biological, psychological, and social factors interact to inf…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- West Virginia University, Morgantown, West Virginia
- Run by
- West Virginia University
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
- Stage
- Not phased
- Ages
- 30 to 65
- Site
- University of Kansas Medical Center, Kansas City, Kansas
- Run by
- Carol Fabian, MD
-
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…
- Stage
- Not phased
- Ages
- Any age
- Site
- Massive Bio SYNERGY-AI site, Birmingham, Alabama
- Locations
- 68 in total
- Run by
- Massive Bio, Inc.
-
Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
RATIONALE: Collecting and storing samples of tumor tissue from patients with breast cancer to study in the laboratory may help doctors learn more about cancer. PURPOSE: This phase I study is collecting tissue samples for future research from women undergoing surgery for breast cancer.
- Stage
- Not phased
- Ages
- Any age
- Site
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois
- Run by
- Northwestern University
-
Strength After Breast Cancer
The goal of this study is to explore whether a group exercise program called Strength After Breast Cancer can be delivered in an outpatient physical therapy clinic to improve physical function among women after treatment for breast cancer. The main questions this study aims to answer are: * Can the…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- MGH Institute of Health Professions, Boston, Massachusetts
- Run by
- MGH Institute of Health Professions
-
The COMPASSION Study
The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Dana-Farber Cancer Institute, Boston, Massachusetts
- Run by
- Dana-Farber Cancer Institute
-
UCF MammoChat: Image Repository
This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to par…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Central Florida, Orlando, Florida
- Run by
- University of Central Florida
-
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
Breast cancer (BC) is the most frequently diagnosed cancer in women. Systemic cancer treatments are an important contributor to dramatic improvements in the long-term survival of women with BC. However, cancer treatment can lead to cognitive impairment and declines in quality of life in women with …
- Stage
- Not phased
- Ages
- 45 to 75
- Site
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio
- Run by
- Ohio State University Comprehensive Cancer Center
-
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
The goal of this study is to assess the effect of brief mindfulness-guided meditations during radiation therapy (RT) for patients with anxiety related to RT for breast and gynecological cancers.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah
- Run by
- University of Utah
-
All-extremity Exercise During Breast Cancer Chemotherapy
Currently, there are 3.5 million breast cancer survivors in the United States and this number is expected to increase dramatically. The proposed research will examine whether a novel exercise intervention for breast cancer patients who are undergoing chemotherapy protects against cardiovascular dys…
- Stage
- Not phased
- Ages
- 18 to 85
- Site
- Integrative Cardiovasculal Physiology Laboratory, University of Florida, Gainesville, Florida
- Run by
- University of Florida
-
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
This is an open-label, FIH study designed to evaluate the maximum tolerated dose, recommended Phase 2 dose, safety, tolerability, PK, pharmacodynamics, and preliminary antineoplastic activity of RLY-2608, in advanced solid tumor patients with a Phosphatidylinositol-4,5-bisphosphate-3 kinase, cataly…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- The University of Arizona Cancer Center, Tucson, Arizona
- Locations
- 37 in total
- Run by
- Relay Therapeutics, Inc.
-
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small structures in breast tissue more clearly. The investigators also want to find out if using the BCT will provide a more accurate diagnosis of breast cancer.
- Stage
- Not phased
- Ages
- 40 and older
- Site
- University of Arizona, Tucson, Arizona
- Run by
- University of Arizona
-
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enabl…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Providence Alaska Medical Center, Anchorage, Alaska
- Locations
- 134 in total
- Run by
- Agendia
-
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast cancer screening results. The investigators will determine the effectivene…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences, Salt Lake City, Utah
- Run by
- University of Utah
-
Role of the Immune Environment in Response to Therapy in Breast Cancer
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Abramson Cancer Center, Philadelphia, Pennsylvania
- Run by
- Abramson Cancer Center at Penn Medicine
-
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
The purpose of this study is to test BTX-9341 alone or in combination with fulvestrant (a currently marketed medication for breast cancer) in participants with advanced and/or metastatic hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer. The stu…
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Biotheryx Investigative Site, Rochester, Minnesota
- Locations
- 6 in total
- Run by
- Biotheryx, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.